Express Scripts, the nation’s largest pharmacy benefits manager, will limit the number and strength of opioid drugs prescribed to first-time users starting in September 2017 as part of a wide ...

Cigna agreed in March to buy Express Scripts in deal then valued at $67 billion, but it needs shareholder approval to close the transaction. Icahn holds less than 5% of Cigna’s shares.

CVS Health, Express Scripts’ rival and the No. 2 pharmacy benefit manager in the country, has sided with California-based Gilead Sciences and its two hepatitis C drugs, Sovaldi and Harvoni.

Express Scripts said it will pay $9.3 million of the settlement total to the states and the District of Columbia. Another $200,000 will provide no more than $25 apiece to individual patients to ...

Express Scripts' revenue in 2005 was $16.3 billion, making it No. 2 in town behind Emerson's $20.1 billion. (The Emerson figure is for fiscal 2006, which ended in September.) Anheuser-Busch is ...

Express Scripts will use cash on hand, committed debt financing and up to $1.4 billion in stock to pay for the deal, said David Myers, vice president of investor relations.

This July 21, 2011, file photo shows a building on the Express Scripts campus in Berkeley, Mo. Express Scripts, the nation's largest pharmacy benefits manager, is throwing its weight into a fight ...